Sulfamonomethoxine Sodium, identified by its CAS registry number 1037-50-9, stands as a pivotal active pharmaceutical ingredient within the veterinary medicinal field. Recognized for its broad-spectrum antibiotic and antimicrobial properties, this compound is a cornerstone in the treatment and control of various bacterial infections affecting livestock and companion animals. Its efficacy lies in its ability to disrupt essential metabolic pathways in bacteria, specifically inhibiting the synthesis of folic acid, a critical component for bacterial growth and replication.

As a sulfonamide class antibiotic, Sulfamonomethoxine Sodium operates by competitive inhibition of dihydropteroate synthase, an enzyme involved in the conversion of para-aminobenzoic acid (PABA) into dihydrofolic acid. This mechanism starves the bacteria of essential precursors needed for DNA, RNA, and protein synthesis, ultimately leading to bacteriostatic effects. In some cases, particularly at higher concentrations or against susceptible strains, it can be bactericidal. This mode of action is distinct from many other antibiotic classes, making it valuable in combating resistance patterns.

The raw material, typically presented as a white powder, is a crucial intermediate for veterinary drug manufacturers. Its chemical formula is C11H11N4NaO3S, with a molecular weight of 302.28. The appearance of its solution is typically clear and lighter in color than a reference standard, indicating a high degree of purity essential for pharmaceutical applications. Quality standards, such as Medicine Grade and compliance with GMP principles, are paramount to ensure the safety, efficacy, and consistency of the final veterinary drug products formulated using this active ingredient.

The applications of Sulfamonomethoxine Sodium in veterinary medicine are extensive. It is commonly used to treat infections of the respiratory, enteric, and urinary tracts, as well as certain systemic infections caused by susceptible Gram-positive and Gram-negative bacteria. Its long half-life in some species allows for less frequent dosing, contributing to improved compliance and convenience in animal treatment regimens. Conditions such as bacterial pneumonia, enteritis, coccidiosis (in some cases as a co-treatment or preventive), and specific wound infections can be effectively managed with formulations containing Sulfamonomethoxine Sodium. The choice of administration route and specific dosage depends on the animal species, the nature and severity of the infection, and the specific formulation being used (e.g., oral solution, soluble powder for drinking water, injectable solution).

Ensuring a reliable supply of high-quality Sulfamonomethoxine Sodium is critical for the global veterinary pharmaceutical industry. Manufacturers must adhere to stringent quality control measures throughout the production process, from raw material sourcing to final product testing. This includes verification of chemical identity, purity levels, assay strength, moisture content, particle size distribution (if applicable), and absence of impurities. The API must be stable under recommended storage conditions and maintain its potency over its shelf life to guarantee the quality of downstream drug products.

The production capacity of Sulfamonomethoxine Sodium is an important factor for meeting global demand. Large-scale synthesis requires sophisticated chemical engineering processes and rigorous quality management systems. Experienced manufacturers can produce significant quantities annually while maintaining batch-to-batch consistency and full traceability. This capability supports the continuous availability of essential veterinary medicines worldwide, helping to safeguard animal health and welfare.

Sustainability and ethical manufacturing practices are also becoming increasingly important considerations when sourcing pharmaceutical raw materials. Reputable suppliers prioritize environmental protection, worker safety, and compliance with international labor standards. Partnering with a manufacturer that demonstrates a commitment to these principles ensures a responsible supply chain from the initial chemical synthesis to the delivery of the product.

For pharmaceutical companies seeking a dependable supplier of Sulfamonomethoxine Sodium CAS 1037-50-9, establishing a relationship with a proven manufacturer is key. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to providing high-quality active pharmaceutical ingredients, including this essential veterinary antibiotic powder. We understand the critical need for purity, potency, and reliability in the veterinary sector. Potential customers looking to purchase this material for their formulations can inquire directly about product specifications, lead times, and bulk availability.

We welcome discussions regarding your specific needs and can provide detailed information about our manufacturing processes and quality assurance protocols. For those interested in the current market price of Sulfamonomethoxine Sodium CAS 1037-50-9 or wishing to initiate a buy order, our team is ready to assist. As a professional supplier, NINGBO INNO PHARMCHEM CO.,LTD. is committed to facilitating your purchase process and ensuring timely delivery of this vital raw material, supporting your efforts to produce effective veterinary treatments.